December 28, 2016: Markets opened higher Wednesday but any recovery from Tuesday’s end-of-day selling failed to materialize. Trading reversed course from Tuesday, where every S&P sector showed a gain, to a trading…
The December 15 short interest data have been compared with the previous figures, and short interest increased in most of these selected pharmaceutical stocks.
December 21, 2016: Markets opened mixed Wednesday and the consensus opinion seems to be that traders are pausing to think about whether they really want the DJIA to top 20,000. It’s really…
Monday’s top analyst upgrades, downgrades and initiations include Anadarko Petroleum, Bristol-Myers Squibb, Comcast, Walt Disney and Merck.
At the end of each year, investors look for opportunities and safe harbors to park their money for the year ahead. Investors who love dividends often consider the so-called Dogs of the…
The November 30 short interest data have been compared with the previous figures, and short interest decreased in these selected pharmaceutical stocks.
December 9, 2016: Markets opened higher again Friday with little support from either economic data or corporate earnings. One big positive came from the University of Michigan’s consumer sentiment report that posted…
With the top pharmaceutical stocks trailing the market by a large margin, they are starting to look very attractive for long-term growth and income investors.
November 28, 2016: Markets opened lower Monday after a long weekend of eating and shopping. There was no economic news of note, so this may just be a pause in an equity…
The November 15 short interest data have been compared with the previous figures, and short interest was mixed in the selected pharmaceutical stocks.
November 18, 2016: Markets opened higher Friday but the good vibe did not last. The energy sector posted the best gain while the healthcare sector fared worst. As we head into the…
November 16, 2016: Markets opened lower Wednesday but only the Nasdaq Composite has managed to boost itself into positive territory. The tech sector was the day’s leading gainer, but was more than…
Drug prices have been under pressure due to the campaign rhetoric, and short interest has increased in most of these selected pharmaceutical stocks.
November 9, 2016: Markets opened lower again Wednesday following the unexpected results of Tuesday’s election. Overnight DJIA futures dropped some 800 points at one point, but equities gained strength throughout the day…
The relentless populist rhetoric has lowered the prices on some of the top pharmaceutical companies, and long-term growth and income investors have a chance to buy some great stocks on sale.
